Shoshana Eitan

Biography

Selected Publications

• • Madison CA, Kuempel J, Albrecht GL, Hillbrick L, Jayaraman A, Safe S, Chapkin RS, Eitan S (2022). 3,3′-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female mice, Journal of Affective Disorders, 309:201-210

  • Madison, CA, Debler, RA, Vardeleon, NI, Hillbrick, L, Jayaraman A, Safe, S, Chapkin, RS, Eitan, S (2022). Sex-dependent differences in the stress mitigating and antidepressant effects of selective aryl hydrocarbon receptor modulators, Journal of Affective Disorders, 319:213-220

  • Chen J, Yuan M, Madison CA, Eitan S, Wang Y (2022) Blood-brain barrier crossing using magnetic stimulated nanoparticles. Journal of Control Release. 345:557-571

  • Eitan S, Madison CA, Kuempel J. (2021) The self-serving benefits of being a good host: A role for our micro-inhabitants in shaping opioids’ function. Neuroscience and Biobehavioral Reviews, 127:284-295.

  • Madison CA, Eitan S. (2020) Buprenorphine: prospective novel therapy for depression and PTSD. Psychological Medicine, 50(6):881-893.

  • Madison CA, Arora M, Kumar MNVR, Eitan S. (2020) Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice. ACS Chemical Neuroscience, 11(13):1955-1964.

  • Emery MA, Eitan S. (2019) Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis? Progress in Neuro-Psychopharmacology & Biological Psychiatry, 92:428-449.

  • Eitan S, Emery MA, Bates MLS, Horrax C (2017) Opioid addiction: Who are your real friends? Neuroscience and Biobehavioral Reviews, 83:697-712.